Funpep Co., Ltd. (4881)

Overview

FunPep Company Limited is a pioneering entity focused on the research and development of innovative products in the pharmaceutical, cosmetic, and medical device sectors, leveraging the potential of functional peptides. Since its establishment in 2013, the company has been at the forefront of creating solutions for various medical conditions and cosmetic improvements, rooted in Tokyo, Japan. FunPep’s dedication to advancing healthcare and beauty through scientific innovation positions it as a notable player in these industries.

Products and Services

• SR-0379

  A functional peptide designed for the treatment of skin ulcers, showcasing FunPep Company Limited’s commitment to addressing dermatological needs through advanced peptide research.

• FPP003

  An antibody-inducing peptide undergoing Phase II clinical study in Australia for the treatment of psoriasis and a Phase II clinical trial in Japan for ankylosing spondylitis, illustrating the company's global research initiatives towards novel therapeutic agents.

• FPP004X

  This antibody-inducing peptide for pollinosis signifies FunPep’s foray into allergenic diseases, aiming to provide a revolutionary approach in managing allergy symptoms via peptide-based immunotherapy.

• FPP006

  A corona peptide vaccine under development, highlighting FunPep Company Limited's timely and responsive innovation in the face of global health crises, such as the coronavirus pandemic.

• FPP005

  An antibody-including peptide for psoriasis, which demonstrates the company’s continuous effort in expanding its portfolio of peptide-based therapies to address various dimensions of autoimmune skin conditions.